SCHEMBL21653572

SCHEMBL21653572

CC(C)c1ccnc(CC(C)c2ccnc(CC(C)c3cnccn3)n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19308850 0.83 RXRA (0.31) —
SCHEMBL29332958 0.78 RXRA (0.32) —
SCHEMBL22971697 0.74 ALDH1A1 (0.31) —
SCHEMBL22426188 0.73 — —
SCHEMBL20666526 0.72 ALDH1A1 (0.40) —
SCHEMBL18910654 0.71 HRH4 (0.32) —
SCHEMBL21161714 0.71 ALPL (0.39) —
SCHEMBL24185043 0.70 KDM4E (0.30) —
SCHEMBL26396496 0.69 CYP2D6 (0.32) —
SCHEMBL24849264 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200031801-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS GILEAD SCIENCES, INC. 2020-01-30 — — US disclosed
Send feedback